We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.11%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$10.9B
AUM Growth
+$354M
Cap. Flow
-$371M
Cap. Flow %
-3.39%
Top 10 Hldgs %
21.68%
Holding
2,365
New
95
Increased
251
Reduced
1,484
Closed
53

Top Buys

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$12.1M
2
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$11.5M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$7.47M
4
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$6.8M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$5.09M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$65.3M
2
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$17.5M
3
PAA icon
Plains All American Pipeline
PAA
+$17.4M
4
AAPL icon
Apple
AAPL
+$15.4M
5
TRGP icon
Targa Resources
TRGP
+$13.5M

Sector Composition

Rank Sector Weight
1 Technology 20.23%
2 Financials 13.41%
3 Healthcare 12.54%
4 Consumer Discretionary 11.8%
5 Industrials 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HAPN
1676
Happen Inc
HAPN
$2.28B
$381K ﹤0.01%
23,040
-8,468
-27% -$111K
IMKTA icon
1677
Ingles Markets
IMKTA
$1.69B
$381K ﹤0.01%
6,173
– –
MLAB icon
1678
Mesa Laboratories
MLAB
$629M
$380K ﹤0.01%
1,560
-460
-23% -$127K
RUBY
1679
DELISTED
Rubius Therapeutics, Inc
RUBY
$379K ﹤0.01%
+14,292
New +$209K
TBPH icon
1680
Theravance Biopharma
TBPH
$878M
$378K ﹤0.01%
18,524
-2,730
-13% -$51.9K
PLCE icon
1681
Children's Place
PLCE
$53.8M
$378K ﹤0.01%
5,422
-1,679
-24% -$118K
DMC
1682
Del Monte Corp
DMC
$1.45B
$378K ﹤0.01%
13,189
– –
GTHX
1683
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$378K ﹤0.01%
15,694
– –
AMTI
1684
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$377K ﹤0.01%
8,573
+2,959
+53% +$144K
ALEC icon
1685
Alector
ALEC
$232M
$377K ﹤0.01%
18,717
-2,097
-10% -$37.6K
DBD
1686
DELISTED
Diebold Nixdorf Incorporated
DBD
$376K ﹤0.01%
26,638
+5,899
+28% +$81.2K
WKHS icon
1687
Workhorse Group
WKHS
$34.3M
$374K ﹤0.01%
9
-4
-31% -$287K
RDUS
1688
DELISTED
Radius Health, Inc.
RDUS
$374K ﹤0.01%
17,937
-2,947
-14% -$62.1K
PLRX icon
1689
Pliant Therapeutics
PLRX
$66.9M
$374K ﹤0.01%
9,508
+4,633
+95% +$150K
IVR icon
1690
Invesco Mortgage Capital
IVR
$811M
$373K ﹤0.01%
9,314
+4,166
+81% +$157K
LMAT icon
1691
LeMaitre Vascular
LMAT
$1.88B
$373K ﹤0.01%
7,651
– –
PRSU
1692
Pursuit Attractions and Hospitality Inc
PRSU
$1.29B
$373K ﹤0.01%
8,932
– –
SRCE icon
1693
1st Source
SRCE
$2.14B
$372K ﹤0.01%
7,814
– –
ARCT icon
1694
Arcturus Therapeutics
ARCT
$224M
$369K ﹤0.01%
8,939
– –
CAI
1695
DELISTED
CAI International, Inc.
CAI
$369K ﹤0.01%
8,107
– –
QNST icon
1696
QuinStreet
QNST
$1.18B
$369K ﹤0.01%
18,173
– –
ABTX
1697
DELISTED
Allegiance Bancshares
ABTX
$369K ﹤0.01%
9,094
– –
ASO icon
1698
Academy Sports + Outdoors
ASO
$3.03B
$368K ﹤0.01%
13,625
+4,674
+52% +$112K
FBMS
1699
DELISTED
The First Bancshares, Inc.
FBMS
$368K ﹤0.01%
10,042
– –
HTLD icon
1700
Heartland Express
HTLD
$988M
$367K ﹤0.01%
18,769
– –
66 67
68
69 70

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return

MetLife Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, MetLife Investment Management held 2,365 positions worth $10.9B, up 3.3% from $10.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

MetLife Investment Management withdrew a net $371M in Q1 2021, closing 53 positions and reducing 1,484 holdings. Its most notable exit was Plains All American Pipeline, an estimated $17.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, MetLife Investment Management opened a new position in NXP Semiconductors worth $13.3M.

  • MetLife Investment Management's largest Q1 2021 buy was NXP Semiconductors: 66,011 shares worth $13.3M.
  • MetLife Investment Management added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q1 2021, an estimated $11.5M increase.
  • MetLife Investment Management's biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $65.3M.
  • MetLife Investment Management fully exited Plains All American Pipeline in Q1 2021, selling an estimated $17.4M.
  • MetLife Investment Management's ten largest holdings make up 22% of its $10.9B portfolio in Q1 2021.
  • MetLife Investment Management opened 95 new positions and closed 53 in Q1 2021.
  • MetLife Investment Management's portfolio value rose 3.3% quarter-over-quarter to $10.9B.

Based on MetLife Investment Management's 13F filing for Q1 2021, filed 14 May 2021.